Summary
Mutants of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2), which have been shown to be infectious in established cell lines, were tested for ability to replicate and induce syncytium formation in human peripheral blood mononuclear cells (PBMC). Thevpu mutant of HIV-1 showed depressed kinetics of replication in an established T cell line, as reported previously, but in PBMC, its replication was similar to that of the wild type virus. Thevpx gene of HIV-2 was required for efficient virus propagation in PBMC, but not in an established T cell line, as previously reported. However, the growth rates of thevpx mutant in PBMC preparations from two individuals were different. The results of experiments on infection of PBMC with thevif andvpr mutants of HIV-1 and HIV-2 were essentially consistent with previous results of infection of established T cell lines. No negative effect of thenef gene products of HIV-1 and HIV-2 was observed. The abilities of the wild type virus and the mutants of HIV-1 to induce syncytium formation in both PBMC and established cell lines were similar. In contrast, neither the wild type nor any of the mutants of HIV-2 induced syncytium formation in PBMC. These results suggest that the functions of some genes can be detected only in mixed populations or primary cells such as PBMC. Studies on the roles of these genes in PBMC may provide a better understanding of their functions in vivo.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284–291
Adachi A, Ono N, Sakai H, Ogawa K, Shibata R, Kiyomasu T, Masuike H, Ueda S (1991) Generation and characterization of the human immunodeficiency virus type 1 mutants. Arch Virol 117: 45–58
Ahmad N, Venkatesan S (1988)Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241: 1481–1485
Bachelerie F, Alcami J, Hazan U, Israel IN, Goud B, Arenzana-Seisdedos F, Virelizier JL (1990) Constitutive expression of human immunodeficiency virus (HIV)nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity. J Virol 64: 3059–3062
Cheng-Mayer C, Iannello P, Shaw K, Luciw PA, Levy JA (1989) Differential effects ofnef on HIV replication: implications for viral pathogenesis in the host. Science 246: 1629–1632
Cohen EA, Terwilliger EF, Jalinoos Y, Proulx J, Sodroski JG, Haseltine WA (1990) Identification of HIV-1vpr product and function. J AIDS 3: 11–18
Dayton AI, Sodoroski JG, Rosen CA, Goh WC, Haseltine WA (1986) The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44: 941–947
Dedera D, Hu W, Heyden NV, Ratner L (1989) Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells. J Virol 63: 3205–3208
Fisher AG, Ensoli B, Ivanoff L, Chamberlain M, Petteway S, Ratner L, Gallo RC, Wong-Staal F (1987) Thesor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237: 888–893
Fisher AG, Feinberg MB, Josephs SF, Harper ME, Marselle LM, Reyes G, Gonda MA, Aldovini A, Debouk C, Gallo RC, Wong-Staal F (1986) The trans-activator gene of HTLV-III is essential for virus replication. Nature 320: 367–370
Folks T, Benn S, Rabson A, Theodore T, Hoggan MD, Martin M, Lightfoote M, Sell K (1985) Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci USA 82: 4539–4543
Gorman CM, Moffat LF, Howard BH (1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2: 1044–1051
Graham FL, van der Eb AJ (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456–467
Guyader M, Emerman M, Montagnier L, Peten K (1989)Vpx mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J 8: 1169–1175
Hammes SR, Dixon EP, Malim MH, Cullen BR, Greene WC (1989)Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci USA 86: 9549–9553
Hasegawa A, Tsujimoto H, Maki N, Ishikawa K, Miura T, Fukasawa M, Miki K, Hayami M (1989) Genomic divergence of HIV-2 from Ghana. AIDS Res Hum Retroviruses 5: 593–604
Kim S, Ikeuchi K, Byrn R, Groopman J, Baltimore D (1989) Lack of a negative influence on viral growth by thenef gene of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 86: 9544–9548
Matsuura Y, Maekawa M, Hattori S, Ikegami N, Hayashi A, Yamazaki S, Morita C, Takebe Y (1991) Purification and characterization of human immunodeficiency virus type 1nef gene product expressed by a recombinant baculovirus. Virology 184: 580–586
Luciw PA, Cheng-Mayer C, Levy JA (1987) Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proc Natl Acad Sci USA 84: 1434–1438
Niederman TMJ, Thielan BJ, Ratner L (1989) Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc Natl Acad Sci USA 86: 1128–1132
Ogawa K, Shibata R, Kiyomasu T, Higuchi I, Kishida Y, Ishimoto A, Adachi A (1989) Mutational analysis of the human immunodeficiency virusvpr open reading frame. J Virol 63: 4110–4114
Shibata R, Miura T, Hayami M, Ogawa K, Sakai H, Kiyomasu T, Ishimoto A, Adachi A (1990) Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIVAGM. J Virol 64: 742–747
Sodroski J, Goh WC, Rosen C, Dayton A, Terwilliger E, Haseltine W (1986) A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature 321: 412–417
Sodroski J, Goh WC, Rosen C, Tartar A, Portetelle D, Burny A, Haseltine W (1986) Replicative and cytopathic potential of HTLV-III/LAV withsor gene deletions. Science 231: 1549–1553
Strebel K, Daugherty D, Clouse K, Cohen D, Folks T, Martin MA (1987) The HIV “A” (sor) gene product is essential for virus infectivity. Nature 328: 728–730
Strebel K, Klimkait T, Martin MA (1988) A novel gene of HIV-1,vpu, and its 16-kilodalton product. Science 241: 1221–1223
Takebe Y, Seiki M, Fujisawa J, Hoy P, Yokota K, Arai K, Yoshida M, Arai N (1988) SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U 5 segment of human T cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 8: 466–472
Terwilliger E, Burghoff R, Sia R, Sodroski J, Haseltine W, Rosen C (1988) Theart gene product of human immunodeficiency virus is required for replication. J Virol 62: 655–658
Terwilliger EF, Cohen EA, Lu Y, Sodroski JG, Haseltine WA (1989) Functional role of human immunodeficiency virus type 1vpu. Proc Natl Acad Sci USA 86: 5163–5167
Terwilliger E, Sodroski JG, Rosen CA, Haseltine WA (1986) Effects of mutations within the 3′ orf open reading frame region of human T cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity. J Virol 60: 754–760
Wigler M, Pellicer A, Silverstein S, Axel R, Urlaub G, Chasin L (1979) DNA-mediated transfer of the adenine phosphorybosyltransferase locus into mammalian cells. Proc Natl Acad Sci USA 76: 1373–1376
Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA (1988) In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 62: 139–147
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Akari, H., Sakuragi, J., Takebe, Y. et al. Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells. Archives of Virology 123, 157–167 (1992). https://doi.org/10.1007/BF01317146
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01317146